Remove 2013 Remove Patients Remove Physicians
article thumbnail

Should doctors refuse to treat obese patients?

World of DTC Marketing

IN BRIEF: Doctors are not required to treat obese patients who won’t do anything to lose weight but the problem is more than reminding patients they need to get exercise and drop pounds. But what about patients who make no effort to lose weight? Medicare and Medicaid patients specifically cost $61.8

Doctors 250
article thumbnail

Constipation Patients Are Suffering in Silence—Here’s How to Help Them

PM360

1 Yet, most patients haven’t tried prescription therapies, a discovery Phreesia Life Sciences made after surveying 6,780 adults age 18 and older who previously had been diagnosed with or treated for constipation as they checked in for their doctors’ appointments. Address Patients’ Quality of Life. Why the disconnect?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

ELITE 2023 Digital Crusader Don Abramo of Pharming Healthcare Inc.

PM360

Classified as a rare disease back in 2013, it’s estimated only one to two people per million suffer from it around the globe. As Pharming prepared to launch the first treatment for APDS, they needed to get creative to find and educate potential patients as well as the physicians who may be treating them.

article thumbnail

XACT Robotics® Receives FDA Clearance for its ACE Xtend™ Remote Control Unit

Legacy MEDSearch

The first-of-its-kind feature for CT-guided percutaneous procedures is designed to improve physician workflows while limiting physician and other users’ exposure to radiation and reduce physical strain. About XACT Robotics®.

FDA 52
article thumbnail

Driving clinical trial innovation forward with precision medicine

pharmaphorum

Unify, launched in December 2020, is AstraZeneca’s patient app and clinical trial support tool. Attrition in drug development for chronic disease is high, often because the wrong patients are selected for clinical trials,” Challis explained. Dissecting heterogeneity. Digital technology and ‘frictionless’ clinical trials.

article thumbnail

U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare

Clarivate

Health systems will buy or establish an insurance plan to serve as an extension of their continuum of care, a means of directing referral streams to increase revenue and securing control over clinical and formulary decisions for patients.

article thumbnail

How retailers and “payviders” are disrupting U.S. healthcare in 2024

Clarivate

While the key players’ strategies differ, all are focused on bending the cost curve while increasing patient touchpoints and engagement. More recent developments provide a look into Amazon’s interest in treating patients with chronic conditions, including a pharmacy consultation pilot for high-risk seniors with complex medical needs.

Retail 52